Share of Cost, New target identified to combat deadly allergic reactions
A molecular motor that controls the release of inflammatory factors that cause severe and fatal allergic reactions has now been identified by researchers. The study suggests that targeting this motor may be a new way to treat patients undergoing anaphylactic shock.
Researchers in France have identified a molecular motor that controls the release of inflammatory factors that cause severe and fatal allergic reactions. The study, “Kinesin-1 controls mast cell degranulation and anaphylaxis through PI3K-dependent recruitment to the granular Slp3/Rab27b complex,” which will be published online October 24 ahead of issue in The Journal of Cell Biology, suggests that targeting this motor may be a new way to treat patients undergoing anaphylactic shock.